【结 构 式】 |
【药物名称】 【化学名称】N-[5-[(E)-2-Cyano-2-(N,N-diethylcarbamoyl)vinyl]-2-hydroxy-3-nitrophenoxycarbonyl]-3-hydroxy-L-tyrosine methyl ester 【CA登记号】 【 分 子 式 】C25H26N4O10 【 分 子 量 】542.50677 |
【开发单位】Finncovery (Originator), University of Kuopio (Originator) 【药理作用】Antiparkinsonian Drugs, Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems, Extrapyramidal Disorders, Treatment of, NEUROLOGIC DRUGS, COMT Inhibitors, Dopamine Precursors |
合成路线1
Esterification of L-Dopa (I) with thionyl chloride in methanol leads to the methyl ester (II). The phenolic hydroxyls of (II) are further acylated by acetyl chloride in trifluoroacetic acid to produce diacetate (III). Treatment of the protected derivative of L-Dopa (III) with diphosgene gives rise to isocyanate (IV). This is then coupled to entacapone (V) in refluxing acetonitrile to furnish carbamate (VI). The acetate ester groups of (VI) are finally removed by treatment with 3N HCl in acetone.
【1】 Leppanen, J.; et al.; Design and synthesis of a novel L-dopa-entacapone codrug. J Med Chem 2002, 45, 6, 1379. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 15272 | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid; 3-hydroxy-L-tyrosine; Levodopa | 59-92-7 | C9H11NO4 | 详情 | 详情 |
(II) | 29568 | methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | C10H13NO4 | 详情 | 详情 | |
(III) | 61955 | methyl (2S)-2-amino-3-[3,4-bis(acetyloxy)phenyl]propanoate | C14H17NO6 | 详情 | 详情 | |
(IV) | 61956 | methyl (2S)-3-[3,4-bis(acetyloxy)phenyl]-2-isocyanatopropanoate | C15H15NO7 | 详情 | 详情 | |
(V) | 61957 | (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide | C14H15N3O5 | 详情 | 详情 | |
(VI) | 61958 | methyl (2S)-3-[3,4-bis(acetyloxy)phenyl]-2-[({5-[(E)-2-cyano-3-(diethylamino)-3-oxo-1-propenyl]-2-hydroxy-3-nitrophenoxy}carbonyl)amino]propanoate | C29H30N4O12 | 详情 | 详情 |